Literature DB >> 26339420

Association between hormone receptors and HER-2/neu is age-related.

Bo Wang1, Xiaoling Wang1, Yinying Zou1.   

Abstract

PURPOSE: To investigate the association between hormone receptors and HER-2/neu in different age groups of women with breast cancers.
METHODS: A total of 1036 women with breast cancers were recruited. All the patients were divided into nine groups. The expression of hormone receptors and HER-2/neu was studied by IHC, while FISH test was used to determine HER-2/neu status in cases scored IHC 2+. The association between hormone receptors and HER-2/neu in different age groups was evaluated using the χ(2) test. Multivariate analysis was used to find out the independent factors predicting HER-2/neu amplification. Significant findings: The expression of ER and PR was inversely correlated with HER-2/neu status in women aged >40 years. By multivariate analysis, as far as the overall groups were concerned, PR, lymph node status and tumor grade were independently associated with HER-2/neu; Considering the younger age group (≤ 40), the only predictor for HER-2/neu was the tumor grade; Considering the older age group (>40), tumor grade, PR status, tumor size and lymph node status were associated with HER-2/neu overexpression.
CONCLUSIONS: Our data suggest that the association between ER, PR and HER-2/neu is age-related. The negative relationship is only applied for women aged >40 years.

Entities:  

Keywords:  ER; HER-2/neu; PR; breast cancer

Mesh:

Substances:

Year:  2015        PMID: 26339420      PMCID: PMC4555748     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  38 in total

1.  HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.

Authors:  R Zeillinger; F Kury; K Czerwenka; E Kubista; G Sliutz; W Knogler; J Huber; C Zielinski; G Reiner; R Jakesz
Journal:  Oncogene       Date:  1989-01       Impact factor: 9.867

2.  Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit.

Authors:  Wei Du; Michael S Simon
Journal:  Breast Cancer Res Treat       Date:  2005-06       Impact factor: 4.872

3.  The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database.

Authors:  Jarrett Rosenberg; Yen Lin Chia; Sylvia Plevritis
Journal:  Breast Cancer Res Treat       Date:  2005-01       Impact factor: 4.872

4.  Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer.

Authors:  H J Huang; P Neven; M Drijkoningen; R Paridaens; H Wildiers; E Van Limbergen; P Berteloot; F Amant; I Vergote; M R Christiaens
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

5.  HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases.

Authors:  Han Zhang; Guoping Ren; Xiaoling Wang; Jing Zhao; Hongtian Yao; Yanfeng Bai; Wang Bo
Journal:  Breast Cancer Res Treat       Date:  2012-06-08       Impact factor: 4.872

6.  Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor.

Authors:  K S Russell; M C Hung
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

7.  HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.

Authors:  R K Tiwari; P I Borgen; G Y Wong; C Cordon-Cardo; M P Osborne
Journal:  Anticancer Res       Date:  1992 Mar-Apr       Impact factor: 2.480

8.  Breast cancer stage at diagnosis and area-based socioeconomic status: a multicenter 10-year retrospective clinical epidemiological study in China.

Authors:  Qiong Wang; Jing Li; Shan Zheng; Jia-Yuan Li; Yi Pang; Rong Huang; Bao-Ning Zhang; Bin Zhang; Hong-Jian Yang; Xiao-Ming Xie; Zhong-Hua Tang; Hui Li; Jian-Jun He; Jin-Hu Fan; You-Lin Qiao
Journal:  BMC Cancer       Date:  2012-03-29       Impact factor: 4.430

9.  c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.

Authors:  W J Gullick; S B Love; C Wright; D M Barnes; B Gusterson; A L Harris; D G Altman
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

10.  Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.

Authors:  P V Maynard; C J Davies; R W Blamey; C W Elston; J Johnson; K Griffiths
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

View more
  3 in total

1.  Masculinization of Adult Gambusia holbrooki: A Case of Recapitulation of Protogyny in a Gonochorist?

Authors:  Ngoc Kim Tran; Tzu Nin Kwan; John Purser; Jawahar G Patil
Journal:  Biology (Basel)       Date:  2022-04-30

2.  Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda.

Authors:  Angela T Mlole; James J Yahaya; Emmanuel Othieno; Sam Kalungi; Andrew L Okwi
Journal:  Int J Womens Health       Date:  2020-11-27

3.  Evaluation of Immunohistochemistry-Equivocal (2+) HER2 Gene Status in Invasive Breast Cancer by Silver DNA in Situ Hybridization (SISH) and its Association with Clinicopathological Variables.

Authors:  Zaidoon A Musa; Ban J Qasim; A Wahab A K Al Shaikhly
Journal:  Iran J Pathol       Date:  2016-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.